COLPAL:NSE:NSE-Colgate Palmolive (India) Limited (INR)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 3740.05

Change

-98.05 (-2.55)%

Market Cap

USD 1,044.25B

Volume

0.40M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, rinses, hand washes, and shower gels under the Colgate brand name. It also offers soaps, cosmetics, and toilet preparations. The company exports its products. Colgate-Palmolive (India) Limited was incorporated in 1937 and is headquartered in Mumbai, India. Address: Colgate Research Centre, Mumbai, India, 400076

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
HINDUNILVR:NSE Hindustan Unilever Limited

-44.60 (-1.54%)

USD 7,016.11B
GODREJCP:NSE Godrej Consumer Products Limit..

-5.15 (-0.38%)

USD 1,455.25B
DABUR:NSE Dabur India Limited

-7.75 (-1.34%)

USD 1,015.26B
MARICO:NSE Marico Limited

-8.85 (-1.27%)

USD 897.07B
PGHH:NSE Procter & Gamble Hygiene and H..

+121.00 (+0.73%)

USD 529.76B
EMAMILTD:NSE Emami Limited

-1.60 (-0.21%)

USD 323.99B
GILLETTE:NSE Gillette India Limited

+82.15 (+0.97%)

USD 278.00B
JYOTHYLAB:NSE Jyothy Labs Limited

+1.50 (+0.28%)

USD 197.04B
HONASA:NSE Honasa Consumer Limited

-20.00 (-4.47%)

USD 148.43B
BAJAJCON:NSE Bajaj Consumer Care Limited

+1.92 (+0.81%)

USD 33.88B

ETFs Containing COLPAL:NSE

INCO Columbia India Consumer E.. 0.00 % 0.77 %

-0.87 (0.00%)

N/A
RXD-U:CA 0.00 % 0.00 %

N/A

N/A
RXD:CA RBC Quant Emerging Market.. 0.00 % 0.77 %

N/A

CAD 0.04B

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 50.44% 100% F 77% C+
Dividend Return 0.40% 20% F 36% F
Total Return 50.84% 100% F 77% C+
Trailing 12 Months  
Capital Gain 87.70% 93% A 81% B-
Dividend Return 1.61% 80% B- 78% C+
Total Return 89.31% 93% A 81% B-
Trailing 5 Years  
Capital Gain 158.65% 86% B+ 37% F
Dividend Return 10.79% 73% C 64% D
Total Return 169.44% 86% B+ 38% F
Average Annual (5 Year Horizon)  
Capital Gain 19.83% N/A N/A 29% F
Dividend Return 21.96% N/A N/A 31% F
Total Return 2.12% N/A N/A 86% B+
Risk Return Profile  
Volatility (Standard Deviation) 28.86% N/A N/A 79% B-
Risk Adjusted Return 76.07% N/A N/A 58% F
Market Capitalization 1,044.25B 87% B+ 95% A

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector